BOARD OF DIRECTORS

 


Thomas N. Kelly
Chairman of the Board since 2018
Born 1963
Thomas Kelly serves as Managing Director of KMK & Associates LLC, a private equity firm with a wide range of interests from agriculture to manufacturing. He is also a Director of The Leaders Bank, headquartered in Oak Brook, Illinois. With diverse leadership roles in numerous companies and civic organizations, Mr. Kelly is a trusted and experienced leader known for his ability to anticipate and navigate business challenges with accountability and transparency. He serves on the Boards of the Donald P. and Byrd M. Kelly Foundation, which primarily supports Catholic education in the Chicago area.

Other appointments: Managing Member of KMK & Associates LLC, Director of Leaders Bank, Director of Grandstand Sportswear and Glassware, Managing Member of 3840 Greenway Circle LLC, Director of Harger Woods Corporate Center LLC, Managing Member of D.P. Kelly & Associates, Director Of Elarasys Worldwide LLC, Director of Continental Community Holdings, Director and Secretary of Donald P. and Byrd M. Kelly Foundation.

Education: Mr. Kelly attended University of Kansas in Lawrence, and is an active alumnus serving as member of the President’s Advisory Council.

Holdings: 30 327 as of 2019-08-29

Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.


 

William Cronin

Chief Executive Officer
Board Member since 2015
Born 1965
William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015.  He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

Other appointments: Chairman of the Board of C3 Device Partners

Education: Mr. Cronin holds BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.

Holdings: 4 245 739 through shareholding in C3 Device Partners as of 2019-08-29.

Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.


 

Greg Dingizian

Board Member since 2019
Born 1960
Greg Dingizian is the owner and CEO of his own holding company, Adma Förvaltnings AB. Greg has extensive experience from leading positions, including the duty as CEO of GOTIC AB, Wihl Sonesson AB, Victoria Park AB and HSB Malmö EK.för and several other companies. He has extensive experience from board work within a number of companies, e.g. as Chairman of the Board of Directors in Annehem Fastigheters AB, Victoria Park AB and Board member in over fifty other companies.

Other appointments: Owner of Adma Förvaltnings AB with multiple holdings in public as well as private companies such as DOXA, Safeture, IDL Biotech, Heliospectra, SBB and Mandiri, Grunda Holdings, Strömbergs, Kollektiva Innovations Studio and Malmö Redhawks Holding.

Education: Courses in Economics at Lund University

Holdings:  9 784 273  through shareholding in Adma Förvaltnings AB   (whereof 1 240 000 has been lent out) and 1 500 000 through shareholding in Skandia as of 2019-09-18.

Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.


 

 


Ingrid Atteryd Heiman

Board Member since 2018
Born 1958

Ingrid Atteryd Heiman has worked with companies spanning the women’s health, food, pharmaceutical, biotech, life science, and financial services industries. Most recently, from 2014 to 2015 she served as Acting Chief Executive Officer of Ellen AB (Publ), a biotech company offering patented probiotic products treated to improve women’s health where she also has served as Chairman of the Board. Ms. Atteryd Heiman’s leadership experience includes services as Chief Executive Officer for three successful companies, several board chairman positions, and board member positions, primarily with those listed on OMX First North Growth and Spotlight Stock Market which demands effective communication with the market and shareholders. She has a proven ability to successfully strategize business development and drive profit and growth. Through her years as a management consultant she has been involved in change management, efficiency optimization, strategy development, mergers, and acquisitions.

Other appointments: Chairman of the Board of Doxa AB (Publ), Director of Redwood Pharma AB (Publ), Director of Herantis Pharma Plc (Publ), Director of Parkinson Research Foundation.

Education: Ms. Atteryd Heiman attended Lund University, where she obtained a BA in Finance and B2B marketing, and Uppsala University where she obtained an MBA in International Business. She has also completed the StyrelseAkademien board member training.

Holdings: 10 000 as of 2019-08-29

Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.


 

Pontus Kristiansson

Board Member since 2019
Born 1971
Pontus Kristiansson is a strategy consultant with Altaverita AB. Pontus has more than 20 years’ experience as founder, CEO and Board executive of several startup and growth businesses. He started his career with the consumer goods marketing company Procter & Gamble and thereafter as a strategy consultant with McKinsey & Co before launching his first technology company 1999. He is also a climate impact investor and Chairman of the investment firm Realinvest AB. He has extensive experience from acting in leading positions and of Board work within a number of companies, e.g. as CEO and Board member of Kollektiva Innovation Studios AB, Vice President of Marketing at Rich Relevance Inc., Board member of IKANO Försäkring AB, CEO and Board member of Avail Intelligence AB, Business Development Consultant at Maersk Data Sverige AB and CEO of Absalon Group AB.

Other appointments: Chairman of the Board of Realinvest AB.

Education: Mr Kristiansson holds a MSc in Engineering from Lund University LTH.

Holdings: 8 000 as of 2019-08-29

Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.


 

Mikael Wahlgren

Board Member since 2018
Deputy Managing Director
Born 1965
Mikael Wahlgren is Owner and Senior Legal Adviser of Linton & Wahlgren AB and has worked as General Counsel for Alfa Lavaland in-house counsel supporting several multinational Swedish and foreign listed companies including Skanska, ABB, Rolls-Royce and NCC. Mr. Wahlgren’s extensive legal expertise in Swedish and international commercial legal matters has earned him a reputation as one of the most respected and sought-out counsels in business today managing, organizing and supporting company leadership, Boards of Directors and other stakeholders with legal guidance, strategic thinking and risk awareness.

Other appointments: Board Chairman of Gran Man AB, Board member of ProstaLund AB (publ), CEO and board member of Linton & Wahlgren AB, Deputy CEO of SenzaGen AB (publ)

Education: Mr Wahlgren holds a Master of Law from the University of Lund in Sweden. He has completed the StyrelseAkademien Chairmen training and EFL’s executive board member training.

Holdings: 10 000 as of 2019-08-29

Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.


SENIOR EXECUTIVES


WILLIAM CRONIN

Chief Executive Officer since 2017 (at Dignitana since 2014)
Born 1965

William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015. He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

Other appointments: Chairman of the Board of C3 Device Partners

Education: Mr. Cronin holds a BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.

Holdings: 4 245 739 through shareholding in C3 Device Partners as of 2019-08-29.

Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.


JAMES MCKINNEY

President and Chief Operating Officer since 2018 (at Dignitana since 2016)
Born 1953

James McKinney brings extensive experience and a proven track record in leadership and operations including physician relations and partnership, program design and implementation, financial performance and system integration.

Jim joined Dignitana in June 2016 as a healthcare consultant. He was appointed COO in November 2016, and President in March 2018. His prior leadership roles include CEO of Clinical Partners and HB Anesthesia Groups and Division President of Iasis, President and COO of Leland Medical, and President and CEO of Brim Healthcare. He also serves as a healthcare consultant to Catholic Healthcare Systems and Catholic Relief Services.

Education: Mr. McKinney holds a BSc and an MBA from Colombia State University


MARY HATCHER

Chief Financial Officer since 2019

Mary Hatcher has more than 20 years of broad, practical experience in diverse industries including retail and telecommunications, after key roles in finance and investor relations at Blockbuster, 7-Eleven and Excel Communications. She has a proven ability to impact business growth and manage through changing and challenging situations and has significant experience leading financial transactions, debt restructuring, strategic negotiations and cost reduction.


CAMERON O’MARA

Vice President Global Sales since 2019
Born 1979

Mr. O’Mara brings extensive experience originating new market opportunities for innovative products and services globally. After beginning his career at Arena Capital Partners LP, a middle market private equity firm in New York City, Cameron co-founded several global clean drinking water companies. As part of his duties he spearheaded project development efforts across over twenty emerging markets; establishing partnerships and formal dialogue with local influencers and government officials throughout. Cameron was invited to discuss creative solutions to improve fresh drinking water supplies and associated health standards with Heads of State and senior government ministers across three different continents.

Other appointments: Director, Hydro Nova LTD

Education: Mr. O’Mara received his BA in Psychology from Harvard College. 


 


MELISSA BOURESTOM

Vice President Marketing and Investor Relations since 2016
Born 1967

Ms. Bourestom brings to Dignitana more than 25 years of experience in marketing, communications, event planning and sales. Her expertise is in building strong customer relationships via traditional and digital marketing strategies. Prior to joining Dignitana, she served as Executive Director of the American Advertising Federation Dallas and directed marketing and sales for myFootpath, an education technology start-up in Chicago. She previously worked in sales for Brinker International, in clinical services at Children’s Medical Center Dallas, and in account management at Spier Advertising NY.

Education: Ms. Bourestom holds a BA from Vanderbilt University – International Communications.


JOSEPHINE DIVERS

Vice President Clinical Oncology Services since 2016
Born 1965

Ms. Divers brings extensive experience in professional, collaborative patient care with the ultimate goal of facilitating patient needs with health care professional’s specialization and unique talents. She has been a registered nurse for over 20 years, and holds the Oncology Nurses Society credentials of certification in Breast Cancer Nursing Care. She has international oncology experience in Canada, the United States, Vietnam and Costa Rica. This includes administrative experience in leadership roles as Operations Manager, Educator and Infusion Clinic Nurse. Prior to joining Dignitana she served as a Registered Clinical Oncology Nurse at Baylor/Sammons Cancer Center. Her research and clinical trial experience include published literature in Cancer medicine, Journal of Oncology Nursing, as well as various findings presented at the national Oncology Nursing Society Congress. She continues to be an active member of the Oncology Nursing Society, serves as a member on various advisory panels, as well as educational presentations and in-services related to breast cancer care, and scalp cooling to nurses, physicians and hospital administrators.

Education: Ms. Divers is a registered nurse and holds BSc from Ryerson University in Toronto, Ontario. She is currently enrolled in Texas Women’s University Masters program in Nursing Education.


DARREN HENDERSON

Vice President Quality and Regulatory Affairs since 2017
Born 1967

Darren has over twenty-eight years’ experience working with class I, II, and III medical device companies such as Johnson and Johnson, GlaxoSmithKline and Thermo Fisher Scientific. His past work includes time in research and development and
managing departments including production, quality assurance and quality control, sales, regulatory affairs, purchasing and warehousing. For the past several years he has worked as a consultant helping global medical device companies meet the demanding regulations of various governmental bodies.

Education: Mr. Henderson holds a B.A. Degree Management, Texas AM University Commerce and a A.A.S. Degree, General Science, Mountain View College. He also holds a Regulatory Affairs Certification (RAC) and is a member of the Regulatory Affairs Professions Society (RAPS.)


Bill Leuchten

Vice President Group US Sales since 2015
Born 1965

Bill has worked in sales and product development for over 30 years, including roles with the automotive aftermarket division with Dow Chemical in Switzerland, South Africa and Detroit, Michigan, as well as sales for Expo Marketing, Inc. and Engineered Adhesive Systems, Inc.. He has worked with scalp cooling for over five years, initially in sales for Chemo Cold Caps, a company providing manual gel caps for scalp cooling.

Education: Mr. Leuchten holds a BA Business Administration for Saint Michaels College

Holdings: C3 Partners


Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90